Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92502672 | 9250267 | 2 | F | 20160624 | 20130424 | 20160708 | EXP | US-RANBAXY-2013US-68032 | RANBAXY | OKUYUCU E, MELEK IM, DUMAN T, TUNC T. HYPOMANIA COMPLICATING TOPIRAMATE THERAPY FOR MIGRAINE PROPHYLAXIS. EUR J NEUROL. 2007;14:E6 | 33.00 | MON | F | Y | 21.00000 | KG | 20160708 | MD | TR | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92502672 | 9250267 | 1 | PS | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | UNK | U | 76327 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92502672 | 9250267 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92502672 | 9250267 | HO |
| 92502672 | 9250267 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92502672 | 9250267 | Accidental exposure to product by child | |
| 92502672 | 9250267 | Ataxia | |
| 92502672 | 9250267 | Confusional state | |
| 92502672 | 9250267 | Dysarthria | |
| 92502672 | 9250267 | Hallucination, visual | |
| 92502672 | 9250267 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |